Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Spero Therapeutics, Inc. (NASDAQ: SPRO)
SPRO Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.70%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
SPRO Stock Analysis
SPRO
PE Ratio:
10.4
SPRO
PEG Ratio:
Not Available
SPRO
Forward EPS Growth (12 month):
0.00%
SPRO
PS Ratio:
2.6
SPRO
PSG Ratio:
Not Available
SPRO
Forward Revenue Growth (12 month):
0.00%
SPRO Articles
No data was found